Alpha Tau(DRTS) - 2021 Q4 - Annual Report

Exhibit 99.1 Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update -Debuted as publicly-traded oncology company in March 2022 under symbol DRTS while raising approximately $90 million in gross proceeds- -100% complete response (CR) observed in U.S. multi-center pilot trial of skin cancers at 12 weeks- -Targeted start of U.S. multi-center pivotal trial in skin cancers by the middle of 2022- JERUSALEM, March 28, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS and ...